文献速递肿瘤 PET/CT核素与放射性配体治疗

成纤维细胞激活蛋白抑制剂(FAPI)PET在肉瘤中的应用:进展与未来展望

Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective.
PubMed 文献 · Semin Nucl Med · 2025-06-01

本文综述FAPI PET显像在肉瘤诊断、分期和治疗监测中的潜在价值。多项研究显示FAPI PET在肉瘤中具有应用潜力,FAPI摄取变化与治疗结局相关;但肉瘤间及瘤内异质性可能影响FAP表达的均匀性和FAPI PET显像的有效性。结论认为FAPI PET是核医学与肿瘤学的重要进展,但需进一步研究以全面了解其在临床中的潜力和局限。

要点

  • FAPI PET在肉瘤诊断、分期和治疗监测中显示出应用潜力。
  • FAPI摄取变化与治疗结局相关,可用于评估治疗反应。
  • 肉瘤间及瘤内异质性可能影响FAP表达均匀性和FAPI PET显像有效性。

核心结论

  • FAPI PET显像的引入是核医学与肿瘤学领域的重要进展,随着对该新技术理解的深入,有望在抗癌中发挥越来越重要的作用。
  • 与任何新技术一样,仍需进一步研究以全面了解FAPI PET显像在临床环境中的潜力和局限性。

研究设计与样本

  • 本文为综述,旨在探讨FAPI PET显像在肉瘤诊断、分期和治疗监测中的潜力。

主要发现

  • 多项研究已证明FAPI PET在肉瘤中的潜力。
  • FAPI PET显像在评估治疗反应方面显示出潜力,FAPI摄取变化与治疗结局相关。
  • 肉瘤的间及瘤内异质性可能影响FAP表达的均匀性,从而影响FAPI PET显像的有效性。

局限性

  • 肉瘤的间及瘤内异质性可能影响FAP表达的均匀性,从而影响FAPI PET显像的有效性。
  • 仍需进一步研究以全面了解FAPI PET显像在临床环境中的潜力和局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nuclear medicine has seen significant advancements in recent years, especially in the area of Positron Emission Tomography (PET) imaging. One of these innovations is the use of Fibroblast Activation Protein Inhibitors (FAPI) as a novel radiotracer. FAPI PET imaging has shown promising results in various malignancies, including sarcomas, which are a diverse group of cancers originating from mesenchymal cells. This review aims to explore the potential of FAPI PET imaging in the diagnosis, staging, and treatment monitoring of sarcomas. Several studies have demonstrated the potential of FAPI PET in sarcomas. Furthermore, FAPI PET imaging has shown potential in assessing treatment response, with changes in FAPI uptake correlating with treatment outcomes. However, there are challenges to be addressed. The heterogeneity of sarcomas, both inter- and intra-tumoral, may affect the uniformity of Fibroblast Activation Protein (FAP) expression and thus the effectiveness of FAPI PET imaging. In conclusion, the introduction of FAPI PET imaging represents a significant advancement in the field of nuclear medicine and oncology. As we continue to deepen our understanding of this novel imaging technique, it is hoped that FAPI PET imaging will play an increasingly important role in the fight against cancer. However, as with any new technology, further research is needed to fully understand the potential and limitations of FAPI PET imaging in the clinical setting.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Delgado Bolton RC, Calapaquí Terán AK, Santiago Almeida L, et al. Fibroblast Activation Protein Inhibitor (FAPI) PET in Sarcoma: An Update and Future Perspective. Semin Nucl Med. 2025. PMID: 40456674. doi:10.1053/j.semnuclmed.2025.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。